Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

dATP

Experimental

Small Molecule

dATP

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Technical identifiers

Chemical Formula: C₁₀H₁₆N₅O₁₂P₃
CAS Number: 1927-31-7
UNII ID: K8KCC8SH6N

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Mitochondrial protein
Applicant: WALKER JOHNPriority: 2001
US
CONTROL OF BIOFILM FORMATION
Applicant: XI CHUANWUPriority: 2011
US
2 publications
Ligand, preparation method thereof, fluorescent probe, and preparation method and application of fluorescent probe
Applicant: ACCURATE BIOTECHNOLOGY HUNAN CO LTDPriority: 2019
CN
Composition for analyzing nucleic acid
Applicant: KIKKOMAN CORPPriority: 2007
US
GENERATION OF DEOXYADENOSINE TRIPHOSPHATE DONOR CELLS AND USES THEREOF
Applicant: UNIV WASHINGTONPriority: 2024
US
Enzyme participating in synthesis of phage diaminopurine and application thereof
Applicant: UNIV TIANJINPriority: 2021
CN
2 publications
Cell and gene based methods to improve cardiac function
Applicant: REGNIER MICHAELPriority: 2012
CN
US
2 publications
Engineering the RRM2 subunit of ribonucleotide reductase to resist degradation
Applicant: UNIV WASHINGTONPriority: 2019
US
2 publications